Problemi speciali
L’idrosadenite suppurativa nella popolazione pediatrica
Hidradenitis suppurativa in paediatric population
Benedetta Bossini1, Michele Mazzolai1, Alberto Tommasini2, Sergio Crovella2, Irene Berti2, Egidio Barbi1,2
1Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste
2IRCCS Materno-Infantile “Burlo Garofolo”, Trieste
Gennaio 2019 - pagg. 28 -32
Abstract
Hidradenitis suppurativa (HS) is a chronic and recurrent skin disease affecting apocrine
gland-bearing regions. Typical lesions are nodules and abscesses that result in sinus
tracts, fistulas and eventually scarring. Prepubertal onset of HS is quite rare, representing
only 2% of all HS cases, which are frequently expression of genetic forms, hormonal
imbalances or systemic autoinflammatory diseases. Therapy is severity-tailored ranging
from topical antibiotics to monoclonal antibodies, saving surgery for unresponsive cases.
Early diagnosis and prompt treatment are fundamental to arrest disease progression
to milder stages, giving children the opportunity to keep a good quality of life without
getting stuck on this condition.
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Saunte DML, Jemec GBE. Hidradenitis
suppurativa: advances in diagnosis and treatment.
JAMA 2017; 318(20): 2019-32.
2. Liy-Wong C, Pope E, Lara-Corrales I. Hidradenitis
suppurativa in the pediatric population.
J Am Acad Dermatol 2015;73(5 Suppl
1):S36-41.
3. Vekic DA, Frew J, Cains GD. Hidradenitis
suppurativa, a review of pathogenesis, associations
and management. Part 1. Australas J
Dermatol 2018;59(4):267-77.
4. Napolitano M, Megna M, Timoshchuk
EA, et al. Hidradenitis suppurativa: from
pathogenesis to diagnosis and treatment.
Clin Cosmet Investig Dermatol 2017;10:105-
15.
5. Braunberger TL, Nicholson CL, Gold L, et
al. Hidradenitis suppurativa in children: The
Henry Ford Experience. Pediatr Dermatol
2018;35(3):370-3.
6. Mikkelsen PR, Jemec GB. Hidradenitis
suppurativa in children and adolescents: a
review of treatments options. Paediatr Drugs
2014;16(6):483-9.
7. Scheinfeld N. Hidradenitis suppurativa in
prepubescent and pubescent children. Clin
Dermatol 2015;33(3):316-9.
8. Vekic DA, Cains GD. Hidradenitis suppurativa,
a review of pathogenesis, associations
and management. Part 2. Australas J Dermatol
2018;59(4):261-6.
9. Vekic DA. Hidradenitis suppurativa - Management
comorbities and monitoring. The
Royal Australian College of Practitioner,
2017.
10. Randhawa HK, Hamilton J, Pope E. Finasteride
for the treatment of hidradenitis suppurativa
in children and adolescentes. JAMA
Dermatol 2013;149(6):732-5.
11. Mota F, Machado S, Selores M. Hidradenitis
suppurativa in children treated with finasteride:
a case series. Pediatr Dermatol
2017; 34(5):578-583.
12. Palmer RA, Keefe M. Early-onset hidradenitis
suppurativa. Clin Exp Dermatol 2001;
26(6):501-3.
Corrispondenza: michele.mazzolai90@gmail.com